Computational Medicine and Drug Designing Software Market

Computational Medicine and Drug Designing Software Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 - 2026

Computational Medicine and Drug Designing Software Market Segmented By product type such as Database, Software, application in Drug Discovery And Development, Computational Physiological Medicine, Disease Modeling, Medical Imaging, Predictive Analysis Of Drug Targets, Simulation Software, Cellular Simulation

Industry: IT and Telecommunication

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Report Type: Ongoing

Report ID: PMRREP27037

Report Price

$ 4900*

Pre Book

Introduction

With the introduction of computers, transformation of theoretical chemistry into computational chemistry to understand the interaction of biologic molecules and drugs has become easier. Computational medicine and drug discovery software are used to create innovative solutions for clinical problems to improve human health.

Advantages of computational medicine and drug discovery software in data collection process and in providing valuable insights of experimental findings have accelerated their clinical applications. In computational medicine and drug discovery software, database or repositories of clinical information is used in constraint-based models to understand protein ligand-interaction. It is also used to study the process of disease development and different biological systems.

In the recent years, computational medicine and drug discovery software are gaining increasing application for their advantages in testing new drugs and treatment for several complex disease. They play an important role in the development of bioactive compounds and in different phases of drug development.

Dynamics

Computational medicine and drug discovery software market is expected to witness a steady growth with increasing research activities on drug designing and development. Given the usefulness in drug development, government as well as private companies are increasing investment in R&D is likely to fuel growth in the computational medicine and drug discovery software market.

Emerging trends of consuming personalized medicine is expected to augur well with the growth of computational medicine and drug discovery software market. Further, reduction in the cost of drug designing and development due to implementation of computational medicine and drug discovery software will possibly enhance the lucrativeness of the market in the coming years.

Advancement of information technology along with the advent of fast and accurate computational platforms has considerably reduced the time taken for drug discovery and development.

This is likely to remain a growth driving factor of the market. In addition, rising bioinformatics in drug discovery, evolution of three dimensional drug discovery methodology, and prevalence of drug discovery failure in last stage will possibly continue to open new opportunities for computational medicine and drug discovery software market. Growth in research contribution with participation of entities from various regions across the world coupled with increasing biotech customers promotes a positive outlook of the global market.

Computational Medicine and Drug Discovery Software Market Segmentation

Based on product type
  • Database
  • Software
  • Others
Based on application
  • Drug Discovery And Development
  • Computational Physiological Medicine
  • Disease Modeling
  • Medical Imaging
  • Predictive Analysis Of Drug Targets
  • Simulation Software
  • Cellular Simulation
Region
  •  United States
  • Europe
  • Japan
  • China
  •  India
  • Southeast Asia

Computational Medicine and Drug Discovery Software Market: Regional Outlook

The market size of computational medicine and drug discovery software is expected to be valued high in the North America region. The U.S will witness the highest demand for computational medicine and drug discovery software market in North America. As compared to North America, growth is likely to remain sluggish in Latin America.

With advancement in pharmaceutical industries, Europe will possibly represent a lucrative market for computational medicine and drug discovery software. Further, Asia Pacific presents a significant growth opportunities for computational medicine and drug software market with growing adoption of technological innovations in the field of medicine. The market is expected to grow robustly across developing nations including China, Japan, and India.

Computational Medicine and Drug Discovery Software: Key Market Participants

Key market participants in the computational medicine and drug discovery software market are focusing on improving their product portfolio to suit typical specifications of each application. Rise of technological advancements and M&A activities in the industry are constantly increasing the market competition. Some of the market participants identified across the value chain include:

  • Entelos Inc
  • Crown Bioscience Inc
  • Chemical Computing Group Inc
  • Nimbus Therapeutics Inc
  • Schrodinger Llc
  • Dassault Systemes
  • Genedata Ag
  • Biognos Ab
  • Leadscope Inc
  • Rhenovia Pharma Limited
  • Compugen

The report covers exhaustive analysis on computational medicine and drug discovery software market includes

  • Computational Medicine and Drug Discovery Software Market Segments
  • Computational Medicine and Drug Discovery Software Market Dynamics
  • Computational Medicine and Drug Discovery Software Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Report Highlights

The research report presents a comprehensive assessment of the computational medicine and drug designing software market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report on computational medicine and drug discovery software market provides analysis and information according to market segments such as product type, application and geographies.

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth computational medicine and drug discovery software market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate